Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort study

AbstractNeuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune inflammatory disease that can affect multiple generations and cause complications with long-term prednisolone treatment. This study aimed to evaluate the efficacy and safety of mycophenolate mofetil (MMF) in preventing NMOSD...

Full description

Bibliographic Details

Published in:	Immunological Medicine
Main Authors:	Ritsu Akatani, Norio Chihara, Shusuke Koto, Sotaro Mori, Takuji Kurimoto, Makoto Nakamura, Hisatsugu Tachibana, Yoshihisa Otsuka, Takehiro Ueda, Takashi Omori, Kenji Sekiguchi, Riki Matsumoto
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-04-01
Subjects:	Mycophenolate mofetil neuromyelitis optica spectrum disorder steroid reduction immunosuppressive therapy
Online Access:	https://www.tandfonline.com/doi/10.1080/25785826.2024.2304364